Black Friday Sale - Get 40% off Vantage

Published 9 hours ago • loading... • Updated 7 hours ago

Questions on how new IRA drug prices will affect MFN agreements - Pharmaceutical Technology

Summary by Pharmaceutical-technology.com

The second round of IRA negotiations brings the total number of negotiated drugs to 25.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

2 Articles

Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says

The new negotiated prices for Novo Nordisk’s GLP-1 drugs under the Inflation Reduction Act have raised questions about how they will impact the prices Novo agreed to under its separate “most favored nation” deal with the White House.

7 hours ago

Read Full Article

pharmaceutical-technology.com

Questions on how new IRA drug prices will affect MFN agreements - Pharmaceutical Technology

The second round of IRA negotiations brings the total number of negotiated drugs to 25.

9 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated2 hours agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmaceutical-technology.com broke the news in 9 hours ago on Wednesday, November 26, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics